During the past decade, Cairn Diagnostics conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Cairn Diagnostics" are "Gastroparesis" (4 trials). Many other conditions were trialed in "Cairn Diagnostics" in a lesser frequency.

Most popular intervention types in "Cairn Diagnostics" are "Device" (2 trials) and "Diagnostic Test" (2 trials). Other intervention types were less common.

The name of intervention was led by "13C-Spirulina GEBT" (1 trials), "ABCA2 GIRMS" (1 trials), "Approved GEBT test meal" (1 trials) and "GEBT Telehealth Administration Usability" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cairn Diagnostics" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Cairn Diagnostics". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Cairn Diagnostics, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Cairn Diagnostics, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 4 trials that are defined as “Not Applicable".